Quick Answer
Opus Genetics, Inc. reported Operating Income Loss of -$38.60 million for the year ending 2025.
- Opus Genetics, Inc. showed an increase of +37.8% in Operating Income Loss from 2024 to 2025.
- This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: -$1.91 million | Q2 2013: -$1.91 million | Q3 2013: -$1.82 million | Q1 2014: -$2.77 million | Q2 2014: -$3.51 million | Q3 2014: -$3.14 million | Q4 2014: -$3.85 million | Q1 2015: -$4.42 million | Q2 2015: -$4.82 million | Q3 2015: -$4.66 million | Q4 2015: -$4.37 million | Q1 2016: -$4.86 million | Q2 2016: -$3.91 million | Q3 2016: -$3.72 million | Q4 2016: -$3.92 million | Q1 2017: -$3.95 million | Q2 2017: -$4.28 million | Q3 2017: -$4.22 million | Q4 2017: -$4.90 million | Q1 2018: -$5.89 million | Q2 2018: -$5.00 million | Q3 2018: -$4.68 million | Q4 2018: -$4.97 million | Q1 2019: -$3.94 million | Q2 2019: -$2.99 million | Q3 2019: -$2.28 million | Q1 2020: -$2.74 million | Q2 2020: -$1.26 million | Q3 2020: -$1.95 million | Q1 2021: -$5.19 million | Q2 2021: -$7.14 million | Q3 2021: -$4.23 million | Q1 2022: -$6.51 million | Q2 2022: -$4.94 million | Q3 2022: -$4.54 million | Q1 2023: -$6.13 million | Q2 2023: -$5.39 million | Q3 2023: $6.39 million | Q1 2024: -$7.71 million | Q2 2024: -$8.33 million | Q3 2024: -$8.01 million | Q1 2025: -$9.93 million | Q2 2025: -$8.91 million | Q3 2025: -$8.31 million.
- Over the full 17 years of available data (2009 to 2025), Opus Genetics, Inc.'s Operating Income Loss has declined by 497.0%.
- Historical annual values: Fiscal year 2025: -$38.60 million | Fiscal year 2024: -$62.07 million | Fiscal year 2023: -$10.56 million | Fiscal year 2022: $18.23 million | Fiscal year 2021: -$22.71 million | Fiscal year 2020: -$19.97 million | Fiscal year 2019: -$4.19 million | Fiscal year 2018: -$20.54 million | Fiscal year 2017: -$17.35 million | Fiscal year 2016: -$16.41 million | Fiscal year 2015: -$18.26 million | Fiscal year 2014: -$13.27 million | Fiscal year 2013: -$7.98 million | Fiscal year 2012: -$6.58 million | Fiscal year 2011: -$16.13 million | Fiscal year 2010: -$10.31 million | Fiscal year 2009: -$6.47 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: